These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 23632485)

  • 1. Circulating microRNAs as potential new biomarkers for prostate cancer.
    Sita-Lumsden A; Dart DA; Waxman J; Bevan CL
    Br J Cancer; 2013 May; 108(10):1925-30. PubMed ID: 23632485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer.
    Farran B; Dyson G; Craig D; Dombkowski A; Beebe-Dimmer JL; Powell IJ; Podgorski I; Heilbrun L; Bolton S; Bock CH
    Carcinogenesis; 2018 Apr; 39(4):556-561. PubMed ID: 29471417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
    Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
    Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
    Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.
    Bertoli G; Cava C; Castiglioni I
    Int J Mol Sci; 2016 Mar; 17(3):421. PubMed ID: 27011184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives.
    Movahedpour A; Ahmadi N; Ghasemi Y; Savardashtaki A; Shabaninejad Z
    J Cell Biochem; 2019 Oct; 120(10):16316-16329. PubMed ID: 31257636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs: macro-utility as markers of prostate cancer?
    Selth LA; Tilley WD; Butler LM
    Endocr Relat Cancer; 2012 Aug; 19(4):R99-R113. PubMed ID: 22492480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer.
    Aghdam AM; Amiri A; Salarinia R; Masoudifar A; Ghasemi F; Mirzaei H
    Crit Rev Eukaryot Gene Expr; 2019; 29(2):127-139. PubMed ID: 31679268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.
    Nguyen HC; Xie W; Yang M; Hsieh CL; Drouin S; Lee GS; Kantoff PW
    Prostate; 2013 Mar; 73(4):346-54. PubMed ID: 22887127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.
    Kachakova D; Mitkova A; Popov E; Popov I; Vlahova A; Dikov T; Christova S; Mitev V; Slavov C; Kaneva R
    DNA Cell Biol; 2015 Mar; 34(3):189-200. PubMed ID: 25521481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Yin C; Fang C; Weng H; Yuan C; Wang F
    Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus encoded circulatory miRNAs for early detection of prostate cancer.
    Kim J; Yun SJ; Kim WJ
    BMC Urol; 2015 Nov; 15():116. PubMed ID: 26612689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs Role in Prostate Cancer.
    Balacescu O; Dumitrescu RG; Marian C
    Methods Mol Biol; 2018; 1856():103-117. PubMed ID: 30178248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
    Gordanpour A; Nam RK; Sugar L; Seth A
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining PHI and miRNAs as Biomarkers in Prostate Cancer Diagnosis and Prognosis.
    Ibrahim NH; Abdellateif MS; Thabet G; Kassem SH; El-Salam MA; El-Leithy AA; Selim MM
    Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs predict biochemical recurrence in prostate cancer patients.
    Selth LA; Townley SL; Bert AG; Stricker PD; Sutherland PD; Horvath LG; Goodall GJ; Butler LM; Tilley WD
    Br J Cancer; 2013 Aug; 109(3):641-50. PubMed ID: 23846169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs as biomarkers in prostate cancer.
    Casanova-Salas I; Rubio-Briones J; Fernández-Serra A; López-Guerrero JA
    Clin Transl Oncol; 2012 Nov; 14(11):803-11. PubMed ID: 22855165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic significance of miR-21, miR-141, miR-18a and miR-221 as novel biomarkers in prostate cancer among Egyptian patients.
    Ibrahim NH; Abdellateif MS; Kassem SH; Abd El Salam MA; El Gammal MM
    Andrologia; 2019 Nov; 51(10):e13384. PubMed ID: 31483058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer.
    Azani A; Omran SP; Ghasrsaz H; Idani A; Eliaderani MK; Peirovi N; Dokhani N; Lotfalizadeh MH; Rezaei MM; Ghahfarokhi MS; KarkonShayan S; Hanjani PN; Kardaan Z; Navashenagh JG; Yousefi M; Abdolahi M; Salmaninejad A
    Pathol Res Pract; 2023 Aug; 248():154618. PubMed ID: 37331185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.